Gelteq Ltd Files 6-K with H1 2024 Financials

Ticker: GELS · Form: 6-K · Filed: Jun 30, 2025 · CIK: 1920092

Gelteq LTD 6-K Filing Summary
FieldDetail
CompanyGelteq LTD (GELS)
Form Type6-K
Filed DateJun 30, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-results, sec-filing, corporate-update

TL;DR

Gelteq dropped its H1 2024 financials via 6-K on June 30th.

AI Summary

Gelteq Limited filed a Form 6-K on June 30, 2025, reporting its unaudited financial results for the six months ended December 31, 2024. The company, previously known as Gelteq Pty Ltd, is incorporated in Australia and operates in the Pharmaceutical Preparations sector. This filing also covers recent corporate developments.

Why It Matters

This filing provides investors with an update on Gelteq's financial performance and recent business activities, crucial for assessing the company's current standing and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing (6-K) providing unaudited results and corporate updates, not indicating significant new risks.

Key Players & Entities

FAQ

What period do the unaudited financial results in this 6-K cover?

The unaudited financial results cover the six months ended December 31, 2024.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed as of June 30, 2025.

What is Gelteq Limited's primary industry classification?

Gelteq Limited's Standard Industrial Classification is Pharmaceutical Preparations [2834].

What was Gelteq Limited's former company name?

Gelteq Limited's former company name was Gelteq Pty Ltd.

Does Gelteq Limited file annual reports under Form 20-F or Form 40-F?

Gelteq Limited indicates it files annual reports under Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 30, 2025 regarding Gelteq Ltd (GELS).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing